<DOC>
	<DOC>NCT02328677</DOC>
	<brief_summary>ColoCare is an international prospective cohort study of stage I-IV colorectal cancer patients (ICD-10 C18-C20).</brief_summary>
	<brief_title>ColoCare Study - Colorectal Cancer Cohort</brief_title>
	<detailed_description>The ColoCare Consortium is a multicenter initiative establishing an international cohort of colorectal cancer (CRC) patients for interdisciplinary studies of CRC prognosis and outcomes with sites at the Fred Hutchinson Cancer Research Center, Seattle (Washington, USA), H. Lee Moffitt Cancer Center and Research Institute, Tampa (Florida, USA), the University Hospital Heidelberg (Germany) and the Huntsman Cancer Institute (Utah, USA). Aims: The ColoCare Study investigates clinical outcomes, including disease-free and overall survival, predictors of cancer recurrence, survival, health-related quality-of-life and treatment toxicities. In addition, cross-sectional analyses of biomarkers and/or health behaviors are undertaken. Patients are recruited at baseline (time of first diagnosis) and followed for up to 5 years at regular timepoints (3m, 6m, 12m, 24m, 36m, 48m, 60m). The cohort includes a comprehensive collection of specimens and data.</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>1. Age 1889 years; 2. Men and Women 3. Newlydiagnosed colon or rectal cancer (stages IIV); CRC in treatment (FHCRC and HCI) 4. English (FHCRC, Moffitt, HCI) or German (University Hospital Heidelberg)speaking; 5. mentally/physically able to consent and participate. if one of the above in not fulfilled insufficient language or consent capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Colorectal cancer</keyword>
	<keyword>rectosigmoid</keyword>
	<keyword>rectum</keyword>
	<keyword>colon</keyword>
</DOC>